1. GPCR/G Protein NF-κB Metabolic Enzyme/Protease Immunology/Inflammation Neuronal Signaling Membrane Transporter/Ion Channel PI3K/Akt/mTOR Stem Cell/Wnt MAPK/ERK Pathway TGF-beta/Smad Epigenetics
  2. Protease Activated Receptor (PAR) NF-κB Reactive Oxygen Species (ROS) Calcium Channel Akt ERK p38 MAPK PKC
  3. 7,4'-Dimethoxy-3-hydroxyflavone

7,4'-Dimethoxy-3-hydroxyflavone is an orally active PAR4 antagonist. 7,4'-Dimethoxy-3-hydroxyflavone inhibits PAR4-mediated human platelet aggregation with an IC50 of 1.4 μM. 7,4'-Dimethoxy-3-hydroxyflavone inhibits PAR4-mediated human platelet aggregation and PAR4 signaling pathways, including NF-κB, Ca2+/protein kinase C, Akt, ERK and p38. 7,4'-Dimethoxy-3-hydroxyflavone prevents vascular PAR4 expression, endothelial dysfunction and ameliorates oxidative stress in Streptozotocin (STZ) (HY-13753)-induced diabetic mice. 7,4'-Dimethoxy-3-hydroxyflavone prevents thrombosis in mice without affecting bleeding time[1][2].

For research use only. We do not sell to patients.

7,4'-Dimethoxy-3-hydroxyflavone Chemical Structure

7,4'-Dimethoxy-3-hydroxyflavone Chemical Structure

CAS No. : 13198-99-7

Size Stock
50 mg   Get quote  
100 mg   Get quote  
250 mg   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Top Publications Citing Use of Products

View All Protease Activated Receptor (PAR) Isoform Specific Products:

View All NF-κB Isoform Specific Products:

View All Calcium Channel Isoform Specific Products:

View All Akt Isoform Specific Products:

View All ERK Isoform Specific Products:

View All p38 MAPK Isoform Specific Products:

View All PKC Isoform Specific Products:

  • Biological Activity

  • Purity & Documentation

  • References

  • Customer Review

Description

7,4'-Dimethoxy-3-hydroxyflavone is an orally active PAR4 antagonist. 7,4'-Dimethoxy-3-hydroxyflavone inhibits PAR4-mediated human platelet aggregation with an IC50 of 1.4 μM. 7,4'-Dimethoxy-3-hydroxyflavone inhibits PAR4-mediated human platelet aggregation and PAR4 signaling pathways, including NF-κB, Ca2+/protein kinase C, Akt, ERK and p38. 7,4'-Dimethoxy-3-hydroxyflavone prevents vascular PAR4 expression, endothelial dysfunction and ameliorates oxidative stress in Streptozotocin (STZ) (HY-13753)-induced diabetic mice. 7,4'-Dimethoxy-3-hydroxyflavone prevents thrombosis in mice without affecting bleeding time[1][2].

In Vitro

7,4'-Dimethoxy-3-hydroxyflavone prevents (DMF-OH) (1-10 μM, 6-48 h) high glucose-induced endothelial PAR4 expression in EA.hy 926 cells[1].

7,4'-Dimethoxy-3-hydroxyflavone (1-10 μM, 6-48 h) prevents high glucose-induced endothelial PAR4 function by abolishing PAR4-mediated Ca2+ responses and reducing Ca2+ responses to AYPGKF-NH₂ (PAR4-activating peptide) or thrombin in EA.hy 926 cells[1].

7,4'-Dimethoxy-3-hydroxyflavone (1-10 μM, 24 h) prevents high glucose-induced PAR4-induced aggravation of endothelial dysfunction in EA.hy 926 cells[1].

7,4'-Dimethoxy-3-hydroxyflavone (1-10 μM, 24 h) prevents high glucose-induced PAR4 expression through inhibition of ROS driven NF-κB activation in EA.hy 926 cells[1].

7,4'-Dimethoxy-3-hydroxyflavone (1-5 μM, 3-5 min) inhibits PAR4-mediated human platelet aggregation and secretion through inhibiting the activation of GPIIb/IIIa, which is the key step for platelet aggregation caused by PAR4-AP[2].

7,4'-Dimethoxy-3-hydroxyflavone (1-5 μM, 1-3 min) inhibits PAR4 downstream signaling pathways, including Ca2+/protein kinase C, Akt, ERK and p38 in platelet[2].

7,4'-Dimethoxy-3-hydroxyflavone (5-20 μM, 10 min) inhibits β-arrestin recruitment to PAR4 concentration-dependently in CHO-K1 cells[2].

7,4'-Dimethoxy-3-hydroxyflavone (5-20 μM, 3 min) enhances the efficacy of Vorapaxar (HY-10119) and Ticagrelor (HY-10064) in inhibiting thrombin-induced platelet aggregation[2].

7,4'-Dimethoxy-3-hydroxyflavone (5-10 μM, 10 min) decreases thrombus formation in whole blood under flow conditions[2].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Real Time qPCR[1]

Cell Line: EA.hy926 cells incubated with high glucose (HG)
Concentration: 1, 3, 10 μM
Incubation Time: 6 h
Result: Inhibited high glucose-induced F2RL3 expression in a concentration-dependent manner, with complete inhibition at 10 μM.

Western Blot Analysis[1]

Cell Line: EA.hy926 cells incubated with high glucose (HG)
Concentration: 10 μM
Incubation Time: 48 h
Result: Abolished the high glucose-induced PAR4 protein expression.

Real Time qPCR[1]

Cell Line: EA.hy926 cells incubated with high glucose (HG)
Concentration: 1, 10 μM
Incubation Time: 24 h
Result: Decreased the expression of VCAM1, ICAM1, CCL2, TNF, IL1B and F3

Immunofluorescence[1]

Cell Line: EA.hy926 cells incubated with high glucose (HG)
Concentration: 10 μM
Incubation Time: 48 h
Result: Prevented the ROS production induced by high glucose.
Abolished high glucose-induced NF-κB activation.
In Vivo

7,4'-Dimethoxy-3-hydroxyflavone (DMF-OH) (20 mg/kg, oral gavage, daily for 21 days) prevents vascular PAR4 expression, endothelial dysfunction and ameliorates oxidative stress in Streptozotocin (STZ) (HY-13753)-induced diabetic mice[1].

7,4'-Dimethoxy-3-hydroxyflavone(1-7.5 mg/kg, i.p., single dose) significantly protects from FeCl3-induced carotid arterial occlusions, without significantly affecting tail bleeding time[2].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: 4 weeks male C57BL/6J mice injected STZ (i.p. 180 mg/kg)[1]
Dosage: 20 mg/kg
Administration: Daily by oral gavage for 21 days
Result: Did not affect STZ-induced hyperglycaemia and body weight loss.
Blunted the up-regulation of PAR4.
Improved the aortic wall thickening and irregular arrangement of smooth muscle cells of tunica media.
Blunted the increased expression of proinflammatory and procoagulant mediators in the aorta and prevented macrophage infiltration.
Prevented diabetes-induced increases in aortic 8-OHdG levels.
Reduced the increased serum MDA levels.
Animal Model: Male Balb/c mice (20-25 g, age 6-8 weeks) model of FeCl3-induced arterial thrombosis[2]
Dosage: 1, 3, and 7.5 mg/kg
Administration: i.p. for 30 min before induction of thrombosis
Result: Prevent thrombosis in mice without affecting bleeding time
Molecular Weight

298.29

Formula

C17H14O5

CAS No.
SMILES

COC1=CC=C(C=C1)C2=C(C(C3=CC=C(C=C3O2)OC)=O)O

Shipping

Room temperature in continental US; may vary elsewhere.

Storage

Please store the product under the recommended conditions in the Certificate of Analysis.

Purity & Documentation
References
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.
  • Molarity Calculator

  • Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass   Concentration   Volume   Molecular Weight *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

 

Requested Quantity *

Applicant Name *

 

Salutation

Email Address *

 

Phone Number *

Department

 

Organization Name *

City

State

Country or Region *

     

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
7,4'-Dimethoxy-3-hydroxyflavone
Cat. No.:
HY-174829
Quantity:
MCE Japan Authorized Agent: